Autoimmune Hemolytic Anemia Overview

Save information for later
Sign Up

Learn About Autoimmune Hemolytic Anemia

View Main Condition: Anemia

What is the definition of Autoimmune Hemolytic Anemia?
Autoimmune hemolytic anemia (AIHA) occurs when your immune system makes antibodies that attack your red blood cells. This causes a drop in the number of red blood cells, leading to hemolytic anemia. Symptoms may include unusual weakness and fatigue with tachycardia and breathing difficulties, jaundice, dark urine and/or splenomegaly. AIHA can be primary (idiopathic) or result from an underlying disease or medication. The condition may develop gradually or occur suddenly.
What are the alternative names for Autoimmune Hemolytic Anemia?
  • Autoimmune hemolytic anemia
  • Acquired autoimmune hemolytic anemia
  • Anemia hemolytic autoimmune
  • Familial auto-immune hemolytic anemia (subtype)
  • Idiopathic autoimmune hemolytic anemia
  • Immuno-hemolytic anemia
Who are the top Autoimmune Hemolytic Anemia Local Doctors?
Advanced in Autoimmune Hemolytic Anemia
Dr. Britt H. Bolemon
Hematology Oncology | Hematology | Oncology
Advanced in Autoimmune Hemolytic Anemia
Dr. Britt H. Bolemon
Hematology Oncology | Hematology | Oncology

Prisma Health University Medical Group

890 W Faris Rd, 
Greenville, SC 
 (93.6 mi)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Britt Bolemon is a Hematologist Oncology specialist and a Hematologist in Greenville, South Carolina. Dr. Bolemon and is rated as an Advanced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Lung Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Bolemon is currently accepting new patients.

Experienced in Autoimmune Hemolytic Anemia
Dr. Padma C. Nadella
Hematology Oncology | Oncology | Hematology
Experienced in Autoimmune Hemolytic Anemia
Dr. Padma C. Nadella
Hematology Oncology | Oncology | Hematology

Northeast Georgia Diagnostic Associates And Clinic, LLC

1240 Jesse Jewell Pkwy Se, Suite 500, 
Gainesville, GA 
 (55.7 mi)
770-536-9864
Languages Spoken:
English, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Padma Nadella is a Hematologist Oncology specialist and an Oncologist in Gainesville, Georgia. Dr. Nadella and is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Nadella is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Autoimmune Hemolytic Anemia
Dr. Christina A. Saurel
Hematology Oncology | Hematology | Oncology
Experienced in Autoimmune Hemolytic Anemia
Dr. Christina A. Saurel
Hematology Oncology | Hematology | Oncology

Northeast Georgia Diagnostic Associates And Clinic, LLC

1240 Jesse Jewell Pkwy Se, Suite 500, 
Gainesville, GA 
 (55.7 mi)
770-536-9864
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Christina Saurel is a Hematologist Oncology specialist and a Hematologist in Gainesville, Georgia. Dr. Saurel and is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Lung Cancer, Multiple Carboxylase Deficiency, Vitamin B12 Deficiency Anemia, and Folate Deficiency. Dr. Saurel is currently accepting new patients.

View All Doctors
What are the latest Autoimmune Hemolytic Anemia Clinical Trials?
A Phase 3, Randomized, Double-blind, Study to Assess Efficacy and Safety of Ianalumab (VAY736) Versus Placebo in Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Who Failed at Least One Line of Treatment
A Phase 3, Randomized, Double-blind, Study to Assess Efficacy and Safety of Ianalumab (VAY736) Versus Placebo in Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Who Failed at Least One Line of Treatment
Enrollment Status: Recruiting
Publish Date: February 17, 2025
Intervention Type: Biological, Drug
Study Phase: Phase 3

Summary: The purpose of this study is to evaluate efficacy and safety of ianalumab compared to placebo in patients with warm autoimmune hemolytic anemia, who failed at least one line of treatment.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study With a Long-term Open-label Extension
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study With a Long-term Open-label Extension
Who is this study for: Adult patients with Warm Autoimmune Hemolytic Anemia
Enrollment Status: Recruiting
Publish Date: February 10, 2025
Intervention Type: Drug
Study Drug: M281
Study Phase: Phase 2/Phase 3

Summary: The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center